Related Experiment Video

Updated: Jul 5, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

[Antihypertensive treatment compliance and obstacles to its improvement. Results of Russian program ARGUS-2]

Zh D Kobalova, E G Starostina, Iu V Kotovskaia

    Terapevticheskii Arkhiv
    |April 30, 2008
    PubMed

    Insights

    Patient adherence to arterial hypertension treatment is low, with forgetting being a primary cause of missed doses. Improving patient education, motivation, and physician communication is crucial for better compliance.

    Area of Science:

    • Cardiology
    • Public Health
    • Patient Adherence Research

    Background:

    • Arterial hypertension (AH) management requires consistent patient adherence to antihypertensive medications.
    • Understanding patient-perceived barriers is essential for optimizing treatment outcomes.

    Purpose of the Study:

    • To investigate the barriers encountered by patients in adhering to adequate treatment for arterial hypertension.

    Main Methods:

    • The ARGUS-2 trial involved an anonymous questionnaire survey of 1298 patients (outpatients and inpatients) across 13 Russian cities.
    • Patients reported on life challenges with hypertension, medication compliance, reasons for missed doses, and drug intake opposition.

    Main Results:

    • Only 37.4% of patients were consistent treatment adopters.
    • Forgetting was the most common reason for missed antihypertensive drug intake.
    • Patients prioritized AH complications as major life problems, unlike physicians who focused on financial/routine issues. Poor self-control and lack of awareness regarding side effects were key barriers.

    Conclusions:

    • Improving patient compliance necessitates a multifaceted approach.
    • Key strategies include enhanced patient education, increased motivation, active patient involvement in treatment, and improved physician-patient communication.
    Abstract

    Related Concept Videos

    Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

    Hypertension IV: Drug Therapy and Lifestyle Modifications

    Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
    Hypertension V: Nursing Management01:23

    Hypertension V: Nursing Management

    The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

    Antihypertensive Drugs: Angiotensin II Receptor Blockers

    In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
    Errors occurring during blood pressure monitoring01:25

    Errors occurring during blood pressure monitoring

    Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
    Several factors...